Others have shown that telomere length, independent of CMV serostatus, is a predictor of the robustness of the B-cell and CD8+ T-cell responses to influenza vaccination in older adults with longer telomere length, respectively, associated with improved antibody responses and increased frequency of M1-specific T cells (75). Here, CD8A is linked to influenza.